000 | 01199 a2200313 4500 | ||
---|---|---|---|
005 | 20250515202506.0 | ||
264 | 0 | _c20100827 | |
008 | 201008s 0 0 eng d | ||
022 | _a1742-7843 | ||
024 | 7 |
_a10.1111/j.1742-7843.2009.00514.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHeld, Thomas K | |
245 | 0 | 0 |
_aPharmacodynamic effects of haematopoietic cytokines: the view of a clinical oncologist. _h[electronic resource] |
260 |
_bBasic & clinical pharmacology & toxicology _cMar 2010 |
||
300 |
_a210-4 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 |
_aErythropoietin _xadverse effects |
650 | 0 | 4 |
_aGranulocyte Colony-Stimulating Factor _xadverse effects |
650 | 0 | 4 |
_aHematopoiesis _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMedical Oncology |
650 | 0 | 4 |
_aNeoplasms _xblood |
650 | 0 | 4 | _aRecombinant Proteins |
650 | 0 | 4 |
_aThrombopoietin _xadverse effects |
700 | 1 | _aGundert-Remy, Ursula | |
773 | 0 |
_tBasic & clinical pharmacology & toxicology _gvol. 106 _gno. 3 _gp. 210-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1742-7843.2009.00514.x _zAvailable from publisher's website |
999 |
_c19430116 _d19430116 |